INSM logo

Insmed Incorporated (INSM)

Profile

Full Name

Insmed Incorporated

Ticker Symbol

INSM

Exchange

NASDAQ

Country

United States

IPO

June 1, 2000

Indexes

Not included

Employees

1271

Key Details

Price

$69.75(-1.80%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$363.71M(+19.17% YoY)

Annual EPS

-$5.57(-4.31% YoY)

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 B of A Securities
Buy
Mar 19, 25 RBC Capital
Outperform
Mar 6, 25 UBS
Buy
Feb 25, 25 RBC Capital
Outperform
Feb 25, 25 Guggenheim
Buy
Feb 24, 25 HC Wainwright & Co.
Buy
Feb 21, 25 Truist Securities
Buy
Feb 21, 25 Stifel
Buy
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 20, 25 Cantor Fitzgerald
Overweight

Institutional Ownership

  • What is the ticker symbol for Insmed Incorporated?
  • Does Insmed Incorporated pay dividends?
  • What sector is Insmed Incorporated in?
  • What industry is Insmed Incorporated in?
  • What country is Insmed Incorporated based in?
  • When did Insmed Incorporated go public?
  • Is Insmed Incorporated in the S&P 500?
  • Is Insmed Incorporated in the NASDAQ 100?
  • Is Insmed Incorporated in the Dow Jones?
  • When was Insmed Incorporated's last earnings report?
  • When does Insmed Incorporated report earnings?
  • Should I buy Insmed Incorporated stock now?

What is the ticker symbol for Insmed Incorporated?

The ticker symbol for Insmed Incorporated is NASDAQ:INSM

Does Insmed Incorporated pay dividends?

No, Insmed Incorporated does not pay dividends

What sector is Insmed Incorporated in?

Insmed Incorporated is in the Healthcare sector

What industry is Insmed Incorporated in?

Insmed Incorporated is in the Biotechnology industry

What country is Insmed Incorporated based in?

Insmed Incorporated is headquartered in United States

When did Insmed Incorporated go public?

Insmed Incorporated's initial public offering (IPO) was on June 1, 2000

Is Insmed Incorporated in the S&P 500?

No, Insmed Incorporated is not included in the S&P 500 index

Is Insmed Incorporated in the NASDAQ 100?

No, Insmed Incorporated is not included in the NASDAQ 100 index

Is Insmed Incorporated in the Dow Jones?

No, Insmed Incorporated is not included in the Dow Jones index

When was Insmed Incorporated's last earnings report?

Insmed Incorporated's most recent earnings report was on Feb 20, 2025

When does Insmed Incorporated report earnings?

The next expected earnings date for Insmed Incorporated is May 9, 2025

Should I buy Insmed Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page